Dr. Umar Wadood, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 4350 Shawnee Mission Pkwy, Suite 252, Fairway, KS 66205 Phone: 913-677-2277 Fax: 913-677-2229 |
Jennifer Ann Liebenthal, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 4350 Shawnee Mission Pkwy, Fairway, KS 66205 Phone: 913-588-6965 |
Dr. Walter Francisco Ricci, M.D. Psychiatry & Neurology - Psychosomatic Medicine Medicare: Medicare Enrolled Practice Location: 4350 Shawnee Mission Pkwy, Suite 252, Fairway, KS 66205 Phone: 913-677-3399 Fax: 913-897-4317 |
Dr. Richard M. Childs, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5800 Windsor Dr, Fairway, KS 66205 Phone: 913-677-1144 |
Dr. Matthew Moser Hastings, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 5641 Fairway Rd, Fairway, KS 66205 Phone: 800-348-4565 Fax: 888-203-4247 |
Melanie Doerflinger Glenn, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 4350 Shawnee Mission Pkwy, Fairway, KS 66205 Phone: 913-588-6970 |
News Archive
Cell Therapeutics, Inc. today announced that it has submitted a formal appeal to the Office of New Drugs in the U.S. Food and Drug Administration's Center for Drug Evaluation and Research regarding the agency's decision from earlier this year on the pixantrone New Drug Application to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
The Family Health Centers at NYU Langone in Sunset Park, Brooklyn, has been awarded a $24 million federal grant through the American Rescue Plan Act of 2021 to advance COVID-19 vaccination and education and expand access to high-quality comprehensive care in some of New York City's lowest-income neighborhoods.
The Hispanic Health Disparities Research Center at the University of Texas at El Paso has received a $6.8 million grant from the National Institutes of Health that will significantly advance the center's research in helping eliminate racial and ethnic health inequalities across the nation.
A low-salt diet does not necessarily translate to stronger bones in postmenopausal women, physician-scientists report.
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.
› Verified 7 days ago